IOLCPPharmaceuticals
IOL Chemicals and Pharmaceuticals Ltd — Profit & Loss Statement
₹72.77
-0.81%
IOL Chemicals and Pharmaceuticals Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.11 Cr | 0.08 Cr | -0.09 Cr | -3.77 Cr |
| Tax Rate For Calcs | 0.27 | 0.26 | 0.26 | 0.25 |
| Normalized EBITDA | 219.43 Cr | 255.11 Cr | 245.86 Cr | 285.38 Cr |
| Total Unusual Items | 0.42 Cr | 0.29 Cr | -0.36 Cr | -14.84 Cr |
| Total Unusual Items Excluding Goodwill | 0.42 Cr | 0.29 Cr | -0.36 Cr | -14.84 Cr |
| Net Income From Continuing Operation Net Minority Interest | 101.07 Cr | 134.43 Cr | 139.14 Cr | 167.67 Cr |
| Reconciled Depreciation | 71.99 Cr | 62.91 Cr | 46.16 Cr | 43.26 Cr |
| Reconciled Cost Of Revenue | 1.41K Cr | 1.42K Cr | 1.58K Cr | 1.60K Cr |
| EBITDA | 219.85 Cr | 255.40 Cr | 245.50 Cr | 270.54 Cr |
| EBIT | 147.86 Cr | 192.49 Cr | 199.34 Cr | 227.28 Cr |
| Net Interest Income | -4.18 Cr | -2.11 Cr | 0.26 Cr | 9.75 Cr |
| Interest Expense | 9.90 Cr | 10.84 Cr | 10.69 Cr | 2.43 Cr |
| Interest Income | 10.58 Cr | 13.99 Cr | 16.73 Cr | 18.04 Cr |
| Normalized Income | 100.76 Cr | 134.22 Cr | 139.41 Cr | 178.74 Cr |
| Net Income From Continuing And Discontinued Operation | 101.07 Cr | 134.43 Cr | 139.14 Cr | 167.67 Cr |
| Total Expenses | 1.94K Cr | 1.95K Cr | 2.02K Cr | 1.95K Cr |
| Rent Expense Supplemental | 1.76 Cr | 1.71 Cr | 0.39 Cr | 0.23 Cr |
| Diluted Average Shares | 29.35 Cr | 29.35 Cr | 29.35 Cr | 29.35 Cr |
| Basic Average Shares | 29.35 Cr | 29.35 Cr | 29.35 Cr | 29.35 Cr |
| Diluted EPS | 3.44 | 4.58 | 4.74 | 5.71 |
| Basic EPS | 3.44 | 4.58 | 4.74 | 5.71 |
| Diluted NI Availto Com Stockholders | 101.07 Cr | 134.43 Cr | 139.14 Cr | 167.67 Cr |
| Net Income Common Stockholders | 101.07 Cr | 134.43 Cr | 139.14 Cr | 167.67 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 101.07 Cr | 134.43 Cr | 139.14 Cr | 167.67 Cr |
| Net Income Including Noncontrolling Interests | 101.07 Cr | 134.43 Cr | 139.14 Cr | 167.67 Cr |
| Net Income Continuous Operations | 101.07 Cr | 134.43 Cr | 139.14 Cr | 167.67 Cr |
| Tax Provision | 36.89 Cr | 47.22 Cr | 49.51 Cr | 57.18 Cr |
| Pretax Income | 137.96 Cr | 181.65 Cr | 188.65 Cr | 224.85 Cr |
| Other Non Operating Income Expenses | 2.98 Cr | 2.46 Cr | 1.52 Cr | 3.31 Cr |
| Special Income Charges | -0.06 Cr | -0.06 Cr | -0.59 Cr | -15.02 Cr |
| Other Special Charges | -0.02 Cr | -0.10 Cr | 0.59 Cr | 15.02 Cr |
| Write Off | 0.08 Cr | 0.16 Cr | 0.00 | — |
| Net Non Operating Interest Income Expense | -4.18 Cr | -2.11 Cr | 0.26 Cr | 9.75 Cr |
| Total Other Finance Cost | 4.86 Cr | 5.26 Cr | 5.78 Cr | 5.86 Cr |
| Interest Expense Non Operating | 9.90 Cr | 10.84 Cr | 10.69 Cr | 2.43 Cr |
| Interest Income Non Operating | 10.58 Cr | 13.99 Cr | 16.73 Cr | 18.04 Cr |
| Operating Income | 130.60 Cr | 167.93 Cr | 180.17 Cr | 216.19 Cr |
| Operating Expense | 523.64 Cr | 527.93 Cr | 444.81 Cr | 355.52 Cr |
| Other Operating Expenses | 176.51 Cr | 218.23 Cr | 177.86 Cr | 115.11 Cr |
| Depreciation And Amortization In Income Statement | 71.99 Cr | 62.91 Cr | 46.16 Cr | 43.26 Cr |
| Depreciation Income Statement | 71.99 Cr | 62.91 Cr | 46.16 Cr | 43.26 Cr |
| Selling General And Administration | 67.86 Cr | 57.94 Cr | 67.68 Cr | 71.34 Cr |
| Selling And Marketing Expense | 62.21 Cr | 51.25 Cr | 61.85 Cr | 66.84 Cr |
| General And Administrative Expense | 5.65 Cr | 6.69 Cr | 5.83 Cr | 4.50 Cr |
| Rent And Landing Fees | 1.76 Cr | 1.71 Cr | 0.39 Cr | 0.23 Cr |
| Gross Profit | 654.24 Cr | 695.86 Cr | 624.98 Cr | 571.71 Cr |
| Cost Of Revenue | 1.41K Cr | 1.42K Cr | 1.58K Cr | 1.60K Cr |
| Total Revenue | 2.07K Cr | 2.12K Cr | 2.20K Cr | 2.17K Cr |
| Operating Revenue | 2.07K Cr | 2.12K Cr | 2.20K Cr | 2.17K Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on IOL Chemicals and Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.